Aragon Pharmaceuticals
Pioneering breakthrough treatments for hormone-resistant prostate and breast cancers.
General Information
Get notified when Aragon Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Aragon Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Aragon Pharmaceuticals
Taxonomy: Pharmaceuticals, Cancer Treatment, Small Molecule Therapeutics, Hormone-Resistant Cancer, Prostate Cancer, Breast Cancer, Discovery-Stage Company, Medical Research, Biomedical Innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 4 |
|
04 Oct 2012 |
| Series C | •••••• | 1 |
|
06 Mar 2012 |
| Series B | •••••• | 3 |
|
22 Apr 2010 |
| Series A | •••••• | 2 |
|
27 May 2009 |
Aragon Pharmaceuticals Alternatives & Competitors
Dana-Farber Cancer Institute is committed to providing expert, compassionate care to children and ad...
Immunotherapeutics against disease-specific targets
-logo.jpg "Michiana Hematology Oncology (MHO)"){kind=logo}
Bringing world-class cancer care to northern Indiana
FAQ About Aragon Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors Aragon Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.